Skip to main content
Top
Published in: Obesity Surgery 9/2010

01-09-2010 | Research Article

Efficacy, Tolerance and Safety of New Intragastric Air-Filled Balloon (Heliosphere BAG) for Obesity: the Experience of 17 Cases

Authors: Paolo Trande, Alessandro Mussetto, Vincenzo G. Mirante, Elvira De Martinis, Giampiero Olivetti, Rita L. Conigliaro, Enrico A. De Micheli

Published in: Obesity Surgery | Issue 9/2010

Login to get access

Abstract

Background

Overweight and obesity lead to serious health consequences, so that many strategies were recommended for preventing or curing this emerging problem. Treatments are various: diet, physical activity, psychotherapy, drugs, and bariatric surgery. Moreover, during these years, the use of intragastric balloon (BIB) to treat obesity increased rapidly, aimed to (1) reduce bariatric surgical risks; (2) reduce general surgical risks; (3) lead to a significant reduction in the prevalence of cardiovascular diseases, diabetes, musculoskeletal disorders and some cancers. Recently, a new device inflated with air to reduce weight has been developed since 2004 (Heliosphere BAG).

Methods

Between March 2006 and September 2006, in our unit, intragastric air-filled balloon insertion was performed under general anesthesia and endoscopic control. The balloons were removed after 6 months. We evaluated efficacy, tolerance, and safety of this technique. Seventeen patients (eight men, nine women), with a mean age of 43 ± 10 years (range 18–65), mean basal BMI of 46 ± 8 (range 35–58) were included, after providing informed consent. Weight and BMI loss were evaluated in all patients.

Results

BMI decreased 4 ± 3 (range +0.33/−11), weight loss was 11 ± 9 kg (range +1/−29.5; 8.5%). 14/17 patients maintain a BMI > 35 at the time of balloon removal. The difference between initial weight and BMI was statistically significant (p = 0.02 for weight and p < 0.01 for BMI, T Student test). Tolerance was very good, limited only to some dyspeptic symptoms during the first 3 days after insertion. One asymptomatic gastric ulcer was seen at the removal of balloon. Only one severe adverse effect was registered at the time of insertion (acute coronary syndrome in patient with chronic coronary disease). No serious technical problems were noted at balloon insertion. Balloon removal was more difficult and successful in 15/17 cases (one distal migration and one patient led to surgery because of balloon fragmentation).

Conclusion

Intragastric air-filled balloon showed a good profile of efficacy and tolerance. Weight loss appeared to be equivalent to other type of balloons. On the other hand, technical problems (especially at the time of removal) probably linked to the device’s material, set a low safety profile.
Literature
1.
go back to reference Melissas J, Christodoulakis M, Spyridakis M, et al. Disorders associated with clinically severe obesity: significant improvement after surgical weight reduction. South Med J. 1998;91:1143–8.PubMed Melissas J, Christodoulakis M, Spyridakis M, et al. Disorders associated with clinically severe obesity: significant improvement after surgical weight reduction. South Med J. 1998;91:1143–8.PubMed
2.
go back to reference WHO. Obesity: preventing and managing the global epidemic. Report of a WHO consultation on obesity. Geneva: WHO; 1998. WHO. Obesity: preventing and managing the global epidemic. Report of a WHO consultation on obesity. Geneva: WHO; 1998.
3.
go back to reference Mion F, Napoléon B, Roman S, et al. Effects of intragastric balloon on gastric emptying and plasma ghrelin levels in non-morbid obese patients. Obes Surg. 2005;15:510–6.CrossRefPubMed Mion F, Napoléon B, Roman S, et al. Effects of intragastric balloon on gastric emptying and plasma ghrelin levels in non-morbid obese patients. Obes Surg. 2005;15:510–6.CrossRefPubMed
4.
go back to reference Melissas J, Mouzas J, Filis D, et al. The intragastric balloon—smoothing the path to bariatric surgery. Obes Surg. 2006;16:897–902.CrossRefPubMed Melissas J, Mouzas J, Filis D, et al. The intragastric balloon—smoothing the path to bariatric surgery. Obes Surg. 2006;16:897–902.CrossRefPubMed
5.
go back to reference Genco A, Bruni T, Doldi SB, et al. BioEnterics intragastric balloon: the Italian experience with 2,515 patients. Obes Surg. 2005;15:1161–4.CrossRefPubMed Genco A, Bruni T, Doldi SB, et al. BioEnterics intragastric balloon: the Italian experience with 2,515 patients. Obes Surg. 2005;15:1161–4.CrossRefPubMed
6.
go back to reference Genco A, Cipriano M, Bacci V, et al. BioEnterics intragastric balloon (BIB): a short-term, double-blind, randomised, controlled, crossover study on weight reduction in morbidly obese patients. Int J Obes (Lond). 2006;30:129–33.CrossRef Genco A, Cipriano M, Bacci V, et al. BioEnterics intragastric balloon (BIB): a short-term, double-blind, randomised, controlled, crossover study on weight reduction in morbidly obese patients. Int J Obes (Lond). 2006;30:129–33.CrossRef
7.
go back to reference Roman S, Napoleon B, Mion F, et al. Intragastric balloon for “non morbid” obesity: a retrospective evaluation of tolerance and efficacy. Obes Surg. 2004;14:539–44.CrossRefPubMed Roman S, Napoleon B, Mion F, et al. Intragastric balloon for “non morbid” obesity: a retrospective evaluation of tolerance and efficacy. Obes Surg. 2004;14:539–44.CrossRefPubMed
8.
go back to reference Al-Momen A, EL-Mogy I. Intragastric balloon for obesity: a retrospective evaluation of tolerance and efficacy. Obes Surg. 2005;15:101–5.CrossRefPubMed Al-Momen A, EL-Mogy I. Intragastric balloon for obesity: a retrospective evaluation of tolerance and efficacy. Obes Surg. 2005;15:101–5.CrossRefPubMed
9.
go back to reference Forestieri P, De Palma GD, Formato A, et al. Heliosphere® bag in the treatment of severe obesity: preliminary experience. Obes Surg. 16:635–7. Forestieri P, De Palma GD, Formato A, et al. Heliosphere® bag in the treatment of severe obesity: preliminary experience. Obes Surg. 16:635–7.
10.
go back to reference Mion F, Gincul R, Romane S, et al. Tolerance and efficacy of an air-filled balloon in non-morbidly obese patients: results of a prospective multicenter study. Obes Surg. 2007;17:764–9.CrossRefPubMed Mion F, Gincul R, Romane S, et al. Tolerance and efficacy of an air-filled balloon in non-morbidly obese patients: results of a prospective multicenter study. Obes Surg. 2007;17:764–9.CrossRefPubMed
11.
go back to reference Boyle TM, Agus SG, Bauer JJ. Small intestinal obstruction secondary to obturation by a Garren gastric bubble. Am J Gastroenterol. 1987;82:51–3.PubMed Boyle TM, Agus SG, Bauer JJ. Small intestinal obstruction secondary to obturation by a Garren gastric bubble. Am J Gastroenterol. 1987;82:51–3.PubMed
12.
go back to reference Ulicny KS Jr, Goldberg SJ, Harper WJ, et al. Surgical complications of the Garren–Edwards gastric bubble. Surg Gynecol Obstet. 1988;166:535–40.PubMed Ulicny KS Jr, Goldberg SJ, Harper WJ, et al. Surgical complications of the Garren–Edwards gastric bubble. Surg Gynecol Obstet. 1988;166:535–40.PubMed
13.
go back to reference Schapiro M, Benjamin S, Blackburn G, et al. Obesity and the gastric balloon: a comprehensive workshop. Florida: Tarpon Springs; 1987. March 19–21. Schapiro M, Benjamin S, Blackburn G, et al. Obesity and the gastric balloon: a comprehensive workshop. Florida: Tarpon Springs; 1987. March 19–21.
Metadata
Title
Efficacy, Tolerance and Safety of New Intragastric Air-Filled Balloon (Heliosphere BAG) for Obesity: the Experience of 17 Cases
Authors
Paolo Trande
Alessandro Mussetto
Vincenzo G. Mirante
Elvira De Martinis
Giampiero Olivetti
Rita L. Conigliaro
Enrico A. De Micheli
Publication date
01-09-2010
Publisher
Springer-Verlag
Published in
Obesity Surgery / Issue 9/2010
Print ISSN: 0960-8923
Electronic ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-008-9786-2

Other articles of this Issue 9/2010

Obesity Surgery 9/2010 Go to the issue